Business Description
Kwality Pharmaceuticals Ltd
ISIN : INE552U01010
Total Employee Number:
997Compare
Compare
Traded in other countries / regions
539997.India IPO Date
2016-07-18Description
Kwality Pharmaceuticals Ltd is an India-based pharmaceutical company. It is principally engaged in manufacturing finished pharmaceutical formulations in a dosage form. The company manufactures and exports pharmaceutical formulations in liquid orals, dry syrups, tablets, capsules, sterile powder for injections, and small-volume injectables.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.1 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.39 | |||||
Debt-to-EBITDA | 1.09 | |||||
Interest Coverage | 8.97 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 8.37 | |||||
Beneish M-Score | -1.36 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 26.1 | |||||
3-Year EBITDA Growth Rate | 37.2 | |||||
3-Year EPS without NRI Growth Rate | 28.8 | |||||
3-Year FCF Growth Rate | -72.6 | |||||
3-Year Book Growth Rate | 18.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 32.29 | |||||
9-Day RSI | 41.14 | |||||
14-Day RSI | 47.14 | |||||
3-1 Month Momentum % | 77.19 | |||||
6-1 Month Momentum % | 163.03 | |||||
12-1 Month Momentum % | 144.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.8 | |||||
Quick Ratio | 1.45 | |||||
Cash Ratio | 0.06 | |||||
Days Inventory | 115.6 | |||||
Days Sales Outstanding | 144.58 | |||||
Days Payable | 101.58 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 48.63 | |||||
Operating Margin % | 19.57 | |||||
Net Margin % | 13.39 | |||||
EBITDA Margin % | 23.91 | |||||
FCF Margin % | -6.43 | |||||
OCF Margin % | 3.3 | |||||
ROE % | 22.81 | |||||
ROA % | 13.32 | |||||
ROIC % | 18.31 | |||||
3-Year ROIIC % | 24.78 | |||||
ROC (Joel Greenblatt) % | 26.97 | |||||
ROCE % | 31.68 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 40.25 | |||||
PE Ratio without NRI | 39.9 | |||||
Shiller PE Ratio | 80.98 | |||||
PEG Ratio | 2.68 | |||||
PS Ratio | 5.39 | |||||
PB Ratio | 8.17 | |||||
Price-to-Tangible-Book | 8.13 | |||||
Price-to-Operating-Cash-Flow | 163.41 | |||||
EV-to-EBIT | 27.5 | |||||
EV-to-EBITDA | 22.98 | |||||
EV-to-Revenue | 5.49 | |||||
EV-to-FCF | -92.65 | |||||
Price-to-GF-Value | 2.17 | |||||
Price-to-Projected-FCF | 10.28 | |||||
Price-to-DCF (Earnings Based) | 1.63 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.61 | |||||
Price-to-Graham-Number | 3.75 | |||||
| Price-to-Net-Current-Asset-Value | 18.25 | |||||
Earnings Yield (Greenblatt) % | 3.64 | |||||
FCF Yield % | -1.23 | |||||
Forward Rate of Return (Yacktman) % | 14.99 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kwality Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 5,030.833 | ||
| EPS (TTM) (₹) | 64.9 | ||
| Beta | 0.6952 | ||
| 3-Year Sharpe Ratio | 1.41 | ||
| 3-Year Sortino Ratio | 3.27 | ||
| Volatility % | 75.24 | ||
| 14-Day RSI | 47.14 | ||
| 14-Day ATR (₹) | 122.028548 | ||
| 20-Day SMA (₹) | 2653.9925 | ||
| 12-1 Month Momentum % | 144.75 | ||
| 52-Week Range (₹) | 828.8 - 2889 | ||
| Shares Outstanding (Mil) | 10.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kwality Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kwality Pharmaceuticals Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 2:1 Stock Split | 2017-10-11 | 47.28 (+5.00%) |
Show
Entries
Kwality Pharmaceuticals Ltd Frequently Asked Questions
What is Kwality Pharmaceuticals Ltd(BOM:539997)'s stock price today?
The current price of BOM:539997 is ₹2551.10. The 52 week high of BOM:539997 is ₹2889.00 and 52 week low is ₹828.80.
When is next earnings date of Kwality Pharmaceuticals Ltd(BOM:539997)?
The next earnings date of Kwality Pharmaceuticals Ltd(BOM:539997) is .
Does Kwality Pharmaceuticals Ltd(BOM:539997) pay dividends? If so, how much?
Kwality Pharmaceuticals Ltd(BOM:539997) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Kwality Pharmaceuticals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers